| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 1 | 60.496 | 71.155 | 92.948 | 100.708 |
| Total Income - EUR | - | - | - | - | - | 1 | 60.497 | 71.156 | 92.950 | 100.710 |
| Total Expenses - EUR | - | - | - | - | - | 2.293 | 16.570 | 20.655 | 30.082 | 34.451 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -2.292 | 43.927 | 50.501 | 62.868 | 66.259 |
| Net Profit/Loss - EUR | - | - | - | - | - | -2.292 | 43.463 | 49.790 | 61.938 | 63.238 |
| Employees | - | - | - | - | - | 0 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Calugaru Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 1.005 | 21.098 | 21.132 | 14.884 | 8.651 |
| Current Assets | - | - | - | - | - | 353 | 20.816 | 41.121 | 54.986 | 57.544 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 5 | 5.181 | 37.488 | 47.945 | 47.755 |
| Cash | - | - | - | - | - | 348 | 15.635 | 3.633 | 7.041 | 9.789 |
| Shareholders Funds | - | - | - | - | - | -2.251 | 41.262 | 50.033 | 62.181 | 63.479 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 3.608 | 652 | 12.219 | 7.689 | 2.716 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Calugaru Med S.r.l.